Press releases - 2025

Domain Therapeutics Doses First Patients in Phase I / II Trial of DT-7012 Targeting CCR8 in Solid Tu...

Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025

Domain Therapeutics to Present Data on its GPCR Lead Programs at AACR Annual Meeting 2025

Domain Therapeutics Discloses DT-9046 as a Groundbreaking Oral Drug Candidate for Inflammatory Disea...

Domain Therapeutics to present and participate at major global healthcare conferences, March to June...